NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Translate Bio Inc (NASDAQ: TBIO)
TBIO Technical Analysis
5
As on 31st Jan 2025 TBIO STOCK Price closed @ 0.28 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.85 & Strong Sell for SHORT-TERM with Stoploss of 1.57 we also expect STOCK to react on Following IMPORTANT LEVELS. |
TBIOSTOCK Price
Open | 0.28 | Change | Price | % |
High | 0.28 | 1 Day | -0.07 | -20.00 |
Low | 0.28 | 1 Week | -0.99 | -77.95 |
Close | 0.28 | 1 Month | -2.95 | -91.33 |
Volume | 488 | 1 Year | -1.64 | -85.42 |
52 Week High 6.04 | 52 Week Low 0.30 |
NASDAQ USA Most Active Stocks
AMRS | 0.14 | 100.00% |
NVDA | 118.65 | 1.71% |
TNXP | 0.15 | -21.05% |
LMDX | 0.02 | 0.00% |
AKTS | 0.04 | 0.00% |
BHAT | 0.04 | -20.00% |
PONO | 1.72 | 2.38% |
TELL | 1.00 | 0.00% |
PLUG | 1.95 | 4.84% |
LCID | 2.93 | 4.64% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
TBIO Daily Charts |
TBIO Intraday Charts |
Whats New @ Bazaartrend |
TBIO Free Analysis |
|
TBIO Important Levels Intraday
RESISTANCE | 0.28 |
RESISTANCE | 0.28 |
RESISTANCE | 0.28 |
RESISTANCE | 0.28 |
RESISTANCE | 0.28 |
RESISTANCE | 0.28 |
RESISTANCE | 0.28 |
RESISTANCE | 0.28 |
TBIO Forecast February 2025
4th UP Forecast | 2 |
3rd UP Forecast | 1.45 |
2nd UP Forecast | 1.11 |
1st UP Forecast | 0.77 |
1st DOWN Forecast | -0.21 |
2nd DOWN Forecast | -0.55 |
3rd DOWN Forecast | -0.89 |
4th DOWN Forecast | -1.44 |
TBIO Weekly Forecast
4th UP Forecast | 1.51 |
3rd UP Forecast | 1.12 |
2nd UP Forecast | 0.87 |
1st UP Forecast | 0.63 |
1st DOWN Forecast | -0.07 |
2nd DOWN Forecast | -0.31 |
3rd DOWN Forecast | -0.56 |
4th DOWN Forecast | -0.95 |
TBIO Forecast2025
4th UP Forecast | 12.07 |
3rd UP Forecast | 8.29 |
2nd UP Forecast | 5.95 |
1st UP Forecast | 3.62 |
1st DOWN Forecast | -3.06 |
2nd DOWN Forecast | -5.39 |
3rd DOWN Forecast | -7.73 |
4th DOWN Forecast | -11.51 |
Translate Bio Inc ( NASDAQ USA Symbol : TBIO )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
TBIO Other Details
Segment | EQ | |
Market Capital | 2823919360.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
TBIO Address
TBIO Latest News
TBIO Business Profile
Translate Bio, Inc., a clinical-stage messenger RNA (mRNA) therapeutics company, develops medicines to treat diseases caused by protein or gene dysfunction. The company is developing MRT5005, which is in Phase I/II clinical trial for the treatment of cystic fibrosis. It is also developing MRT5500 for the treatment of SARS-CoV-2. The company was formerly known as RaNA Therapeutics, Inc. and changed its name to Translate Bio, Inc. in June 2017. Translate Bio, Inc. has a collaboration and license agreement with Sanofi Pasteur Inc. The company was founded in 2011 and is headquartered in Lexington, Massachusetts. As of September 13, 2021, Translate Bio, Inc. operates as a subsidiary of Sanofi. Address: 29 Hartwell Avenue, Lexington, MA, United States, 02421
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service